Protective effects and mechanism of curcumin in animal models of pulmonary fibrosis: a preclinical systematic review and meta-analysis
Frontiers in Pharmacology · 13.10.2023 · 14
DOI: 10.3389/fphar.2023.1258885 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 13.10.2023. Verfasst von Fang Hanyu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Beijing University of Chinese Medicine, Beijing, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
At present, there is a lack of effective treatment for pulmonary fibrosis (PF), and a number of studies have confirmed that curcumin (CUR) has a good effect on PF. Research Qusetion: Is CUR effective in preclinical trials for PF and what is its mechanism of action?
Methods
Animal reports of PF treated with CUR were searched from Pubmed, Embase, Web of Science and Cochrane Library from 1 January 2000 to 19 April 2023 to compare CUR treatment of PF with a no-intervention model group. A previous registration (nsply registration number: INPLASY202360084) of this review protocol was undertaken.
Results
The meta-analysis included 27 publications and 29 studies involving 396 animals. CUR significantly improved the degree of fibrosis, levels of inflammation, and oxidative imbalances in lung tissue in animal models of PF. In terms fibrosis, such as HYP content (SMD = −4.96; 95% CI = −6.05 to −3.87; p = 0.000).In terms of inflammatory indicators, such as MPO activity (SMD = −2.12; 95% CI = −4.93 to 0.69; p = 0.000). In terms of oxidation index, such as MDA (SMD = −5.63; 95% CI = −9.66 to −1.6; p = 0.000).
Conclusion
CUR significantly improved the degree of fibrosis, levels of inflammation, and oxidative imbalances in lung tissue in animal models of PF. Due to the quantitative and qualitative limitations of current research, more high-quality studies are needed to verify the above conclusion.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate School of Beijing University of Chinese Medicine, Beijing, China.
- Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing, China.
- The Second Health and Medical Department, China-Japan Friendship Hospital, Beijing, China.
- Department of Traditional Chinese Medicine for Pulmonary Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
- Department of Traditional Chinese Medicine for Pulmonary Diseases, Jining Hospital of Xiyuan Hospital of China Academy of Chinese Medical Science, Jining, Shandong, China.
Zitieren
APA
Hanyu, F., Zheng, H., Jiaqi, W., Tairan, D., Yiyuanzi, Z., Qiwen, Y., Ying, L., Hongchun, Z., & Lu, L. (2023). Protective effects and mechanism of curcumin in animal models of pulmonary fibrosis: a preclinical systematic review and meta-analysis. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1258885
Vancouver
Hanyu F, Zheng H, Jiaqi W, Tairan D, Yiyuanzi Z, Qiwen Y, et al. Protective effects and mechanism of curcumin in animal models of pulmonary fibrosis: a preclinical systematic review and meta-analysis. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1258885
BibTeX
@article{Hanyu2023,
author = {Hanyu, Fang and Zheng, Hong and Jiaqi, Wang and Tairan, Dong and Yiyuanzi, Zhao and Qiwen, Yang and Ying, Liu and Hongchun, Zhang and Lu, Liu},
title = {Protective effects and mechanism of curcumin in animal models of pulmonary fibrosis: a preclinical systematic review and meta-analysis},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1258885}
}
EUVIMED